AMTD IDEA flagged by NYSE for low ADS trading price
Rhea-AI Filing Summary
AMTD IDEA Group reported that it has received a letter from the New York Stock Exchange stating that its American depositary shares are below compliance standards because the average closing price was under US$1.00 per ADS over a consecutive 30 trading-day period.
The company has six months from receipt of the notice to regain compliance by achieving both a closing price and a 30 trading-day average of at least US$1.00 per ADS, or the NYSE will begin suspension and delisting procedures. AMTD IDEA plans to monitor market conditions and consider measures to cure the non-compliance, and it continues its share repurchase programs, having repurchased 4,417,036 ADSs as of August 7, 2026.
Positive
- None.
Negative
- NYSE non-compliance on US$1.00 ADS price with six‑month delisting risk.
Filing Explained
AMTD IDEA remains in the NYSE’s six-month cure period; it can regain compliance on the last trading day of any cure-period calendar month if both the closing ADS price and trailing 30-trading-day average are at least US$1, otherwise suspension and delisting procedures begin when the period expires.
Key Figures
Key Terms
Section 802.01C regulatory
Cure Period regulatory
delisting procedures regulatory
forward-looking statements regulatory
FAQ
AI-generated questions and answers. How Rhea-AI works. Not financial advice.
Why did AMTD (AMTD IDEA Group) receive a NYSE non-compliance letter?
What minimum ADS price must AMTD (AMTD IDEA Group) meet on the NYSE?
How long does AMTD (AMTD IDEA Group) have to regain NYSE compliance?
What happens if AMTD (AMTD IDEA Group) fails to cure the NYSE deficiency?
How many ADSs has AMTD (AMTD IDEA Group) repurchased so far?
What actions does AMTD (AMTD IDEA Group) plan regarding its NYSE non-compliance?
AI-generated analysis. How Rhea-AI works. Not financial advice.